Closed-loop control of glucose according to a predicted blood glucose trajectory

• US 9,750,878 B2
• Filed: 12/11/2013
• Issued: 09/05/2017
• Est. Priority Date: 12/11/2013
• Status: Active Grant

• Current Assignee: Medtronic Minimed Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Minimed Incorporated (Medtronic Plc)
• Inventors: Roy, Anirban, Keenan, Desmond Barry, Kovelman, Paul H.
• Primary Examiner(s): Mehta, Bhisma
• Assistant Examiner(s): SHAH, NILAY J
• Application Number:
  US14/103,522
• Publication Number:
  US 20150157794A1
• Time in Patent Office: 1,364 Days
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 5/6849 in combination with a needle set
• CPC Class Codes: A61B 5/7275 Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
• CPC Class Codes: A61M 2205/33 Controlling, regulating or measuring
• CPC Class Codes: A61M 2205/50 with microprocessors or computers
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 5/14244 adapted to be carried by the patient, e.g. portable on the body
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G16H 20/17 delivered via infusion or injection

Abstract

Presented here are techniques for controlling glucose levels of a patient based on predicted time to a target glucose level. One methodology predicts a trajectory of the blood glucose level based on past observations of the blood glucose level, determines a cost expression based on the trajectory, and affects a future command to an infusion pump to affect a cost value according to the cost expression. Another methodology defines a target blood glucose concentration level for the patient, observes a current blood glucose concentration for the patient based on signals received from a blood-glucose sensor, and predicts a duration of time for the patient'"'"'s blood glucose concentration to reach the target blood glucose concentration level based on the observed current blood glucose concentration.

Claims

1. A method comprising:

predicting a trajectory of a blood glucose level of a patient based, at least in part, on past observations of said blood glucose level;

determining a cost expression based, at least in part, on said predicted trajectory,

wherein said cost expression is based, at least in part, on a first duration of time that said trajectory is predicted to be under a lower bound blood glucose limit of a target blood glucose concentration range, and is also based, at least in part, on a second duration of time that said trajectory is predicted to be above an upper bound blood glucose limit of said target blood glucose concentration range, the first duration of time corresponding to a predicted hypoglycemic time period, and the second duration of time corresponding to a predicted hyperglycemic time period,

wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range under the lower bound blood glucose limit during said first duration of time, and

wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range above the upper bound blood glucose limit during said second duration of time; and

affecting at least one future command to at least one infusion pump so as to shorten the predicted hypoglycemic time period and to shorten the predicted hyperglycemic time period according to said cost expression.

2. The method of claim 1, wherein said at least one infusion pump comprises an insulin infusion pump.

3. The method of claim 1, wherein said at least one infusion pump comprises an infusion pump for glucagon.

4. The method of claim 1, wherein said cost expression is defined to cover a set duration in the future.

5. The method of claim 1, wherein said predicting, said determining the cost expression and said affecting said at least one future command is performed on command intervals.

6. An apparatus comprising:

one or more infusion pumps to infuse a substance into a body in response to commands; and

a controller to;

predict a trajectory of a blood glucose level of said body based, at least in part, on past observations of said blood glucose level;

determine a cost expression based, at least in part, on said predicted trajectory,

wherein said cost expression is based, at least in part, on a first duration of time that said trajectory is predicted to be under a lower bound blood glucose limit of a target blood glucose concentration range, and is also based, at least in part, on a second duration of time that said trajectory is predicted to be above an upper bound blood glucose limit of said target blood glucose concentration range, the first duration of time corresponding to a predicted hypoglycemic time period, and the second duration of time corresponding to a predicted hyperglycemic time period,

wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range under said lower bound blood glucose limit during said first duration of time, and

wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range above said upper bound blood glucose limit during said second duration of time; and

affect at least one future command to said one or more infusion pumps so as to shorten the predicted hypoglycemic time period and to shorten the predicted hyperglycemic time period wherein the at least one future command controls the system operation according to said cost expression.

7. The apparatus of claim 6, wherein said controller is further to generate said commands on discrete command intervals.

8. The apparatus of claim 6, wherein said one or more infusion pumps comprises an insulin infusion pump.

9. An article comprising:

a non-transitory storage medium comprising machine-readable instructions executable by a special purpose computing apparatus to;

predict a trajectory of a blood glucose level of the body based, at least in part, on past observations of said blood glucose level;

determine a cost expression based, at least in part, on said predicted trajectory,

wherein said cost expression is based, at least in part, on a first duration of time that said trajectory is predicted to be under a lower bound blood glucose limit of a target blood glucose concentration range, and is also based, at least in part, on a second duration of time that said trajectory is predicted to be above an upper bound blood glucose limit of said target blood glucose concentration range, the first duration of time corresponding to a predicted hypoglycemic time period, and the second duration of time corresponding to a predicted hyperglycemic time period,

wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range under said lower bound blood glucose limit during said first duration of time, and

wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range above said upper bound blood glucose limit during said second duration of time; and

affect at least one future command to one or more infusion pumps so as to shorten the predicted hypoglycemic time period and to shorten the predicted hyperglycemic time period according to said cost expression.

10. An apparatus comprising:

a means for predicting a trajectory of a blood glucose level of a patient based, at least in part, on past observations of said blood glucose level;

a means for determining a cost expression based, at least in part, on said predicted trajectory,

wherein said cost expression is based, at least in part, on a first duration of time that said trajectory is predicted to be under a lower bound blood glucose limit of a target blood glucose concentration range, and is also based, at least in part, on a second duration of time that said trajectory is predicted to be above an upper bound blood glucose limit of said target blood glucose concentration range, the first duration of time corresponding to a predicted hypoglycemic time period, and the second duration of time corresponding to a predicted hyperglycemic time period,

wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range under said lower bound blood glucose limit during said first duration of time, and

wherein said cost expression is further based, at least in part, on a degree or extent to which said predicted blood glucose level is to extend outside of the target blood glucose concentration range above said upper bound blood glucose limit during said second duration of time; and

a means for affecting at least one future command to at least one infusion pump to infuse a substance into the patient, and so as to shorten the predicted hypoglycemic time period and to shorten the predicted hyperglycemic time period according to said cost expression.